Your browser doesn't support javascript.
loading
Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).
Ogawa, Satoshi; Minematsu, Kazuo; Ikeda, Takanori; Kitazono, Takanari; Nakagawara, Jyoji; Miyamoto, Susumu; Murakawa, Yuji; Ohashi, Yohei; Takeichi, Makiko; Okayama, Yutaka; Yamanaka, Satoshi; Inuyama, Lyo.
Afiliação
  • Ogawa S; International University of Health & Welfare Mita Hospital Tokyo Japan.
  • Minematsu K; National Cerebral and Cardiovascular Center Suita Osaka Japan.
  • Ikeda T; Department of Cardiovascular Medicine Faculty of Medicine Toho University Tokyo Japan.
  • Kitazono T; Department of Medicine and Clinical Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan.
  • Nakagawara J; Integrative Cerebral and Cardiovascular Imaging Center National Cerebral and Cardiovascular Center Suita Osaka Japan.
  • Miyamoto S; Department of Neurosurgery Kyoto University Graduate School of Medicine Kyoto Japan.
  • Murakawa Y; The 4th Department of Internal Medicine Teikyo University School of Medicine, Mizonokuchi Hospital Kawasaki Japan.
  • Ohashi Y; Medical Affairs Bayer Yakuhin, Ltd.Osaka Japan.
  • Takeichi M; Medical Affairs Bayer Yakuhin, Ltd.Osaka Japan.
  • Okayama Y; Medical Affairs Bayer Yakuhin, Ltd.Osaka Japan.
  • Yamanaka S; Medical Affairs Bayer Yakuhin, Ltd.Osaka Japan.
  • Inuyama L; Medical Affairs Bayer Yakuhin, Ltd.Osaka Japan.
J Arrhythm ; 34(2): 167-175, 2018 04.
Article em En | MEDLINE | ID: mdl-29657592

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article